Surgical Innovations Group (LSE:SUN) Beginning Cash Position: £-0.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Surgical Innovations Group Beginning Cash Position?

Surgical Innovations Group LSE:SUN Beginning Cash Position is £-0.46 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Surgical Innovations Group's Beginning Cash Position for the quarter that ended in Dec. 2025 was £-0.46 Mil.

Surgical Innovations Group's quarterly Beginning Cash Position declined from Dec. 2024 (£0.23 Mil) to Jun. 2025 (£0.20 Mil) and declined from Jun. 2025 (£0.20 Mil) to Dec. 2025 (£-0.46 Mil).

Surgical Innovations Group's annual Beginning Cash Position declined from Dec. 2023 (£2.20 Mil) to Dec. 2024 (£1.21 Mil) and declined from Dec. 2024 (£1.21 Mil) to Dec. 2025 (£0.20 Mil).

Surgical Innovations Group Beginning Cash Position Related Terms

Surgical Innovations Group Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Surgical Innovations Group's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgical Innovations Group Beginning Cash Position Chart

Surgical Innovations Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.28 3.64 2.20 1.21 0.20

Surgical Innovations Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.41 1.21 0.23 0.20 -0.46

Surgical Innovations Group Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of £-0.46 Mil mean?
Surgical Innovations Group (LSE:SUN) has a Beginning Cash Position of £-0.46 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Surgical Innovations Group and its competitors.
Is Surgical Innovations Group's Beginning Cash Position too high?
Surgical Innovations Group's current Beginning Cash Position is £-0.46 Mil.
How does Surgical Innovations Group's Beginning Cash Position compare to ABT and SYK?
Surgical Innovations Group's Beginning Cash Position of £-0.46 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Surgical Innovations Group and its competitors. Surgical Innovations Group's current Beginning Cash Position is £-0.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Surgical Innovations Group stock overvalued right now?
Surgical Innovations Group (LSE:SUN) has a current Beginning Cash Position of £-0.46 Mil. The current Beginning Cash Position is £-0.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Surgical Innovations Group (LSE:SUN), the current Beginning Cash Position is £-0.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Surgical Innovations Group Business Description

Address Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery (SI Brand), along with its label products through original equipment manufacturer (OEM) relationships, including precision engineering markets (PE). The Company's operating segments are SI Brand, OEM, and Distribution. The majority of its revenue is generated from the SI Brand segment, which is involved in the research, development, manufacture, and distribution of SI-branded minimally invasive devices. Geographically, the group derives a majority of its revenue from the United Kingdom, followed by Europe, the United States, the Asia-Pacific region, and the Rest of the world.